These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning. Severson KA; Chahine LM; Smolensky LA; Dhuliawala M; Frasier M; Ng K; Ghosh S; Hu J Lancet Digit Health; 2021 Sep; 3(9):e555-e564. PubMed ID: 34334334 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers in Parkinson's disease: Advances and strategies. Delenclos M; Jones DR; McLean PJ; Uitti RJ Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946 [TBL] [Abstract][Full Text] [Related]
9. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Kang UJ; Goldman JG; Alcalay RN; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Rudolph A; Casaceli C; Andrews H; Gwinn K; Sutherland M; Kopil C; Vincent L; Frasier M Mov Disord; 2016 Jun; 31(6):924-32. PubMed ID: 27113479 [TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics of Parkinson's Disease Developed from Essential Tremor. Ryu DW; Lee SH; Oh YS; An JY; Park JW; Song IU; Lee KS; Kim JS J Parkinsons Dis; 2017; 7(2):369-376. PubMed ID: 28409750 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Gwinn K; David KK; Swanson-Fischer C; Albin R; Hillaire-Clarke CS; Sieber BA; Lungu C; Bowman FD; Alcalay RN; Babcock D; Dawson TM; Dewey RB; Foroud T; German D; Huang X; Petyuk V; Potashkin JA; Saunders-Pullman R; Sutherland M; Walt DR; West AB; Zhang J; Chen-Plotkin A; Scherzer CR; Vaillancourt DE; Rosenthal LS Biomark Med; 2017 May; 11(6):451-473. PubMed ID: 28644039 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for trials of neuroprotection in Parkinson's disease. Agarwal PA; Stoessl AJ Mov Disord; 2013 Jan; 28(1):71-85. PubMed ID: 22927101 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Parkinson's Disease: An Introduction. Titova N; Qamar MA; Chaudhuri KR Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407 [TBL] [Abstract][Full Text] [Related]
14. [Essential tremor and Parkinson's disease: are they associated?]. Labiano-Fontcuberta A; Benito-León J Rev Neurol; 2012 Oct; 55(8):479-89. PubMed ID: 23055430 [TBL] [Abstract][Full Text] [Related]
15. Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data. Adeli E; Shi F; An L; Wee CY; Wu G; Wang T; Shen D Neuroimage; 2016 Nov; 141():206-219. PubMed ID: 27296013 [TBL] [Abstract][Full Text] [Related]
16. Distinguishing essential tremor from Parkinson's disease: clinical and experimental tools. Angelini L; Paparella G; Bologna M Expert Rev Neurother; 2024 Aug; 24(8):799-814. PubMed ID: 39016323 [TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease prognostic scores for progression of cognitive decline. Gramotnev G; Gramotnev DK; Gramotnev A Sci Rep; 2019 Nov; 9(1):17485. PubMed ID: 31767922 [TBL] [Abstract][Full Text] [Related]
18. Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model. Wang M; Li Z; Lee EY; Lewis MM; Zhang L; Sterling NW; Wagner D; Eslinger P; Du G; Huang X BMC Med Res Methodol; 2017 Sep; 17(1):147. PubMed ID: 28946857 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients. Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563 [TBL] [Abstract][Full Text] [Related]
20. Comparison of motor and non-motor features between essential tremor and tremor dominant Parkinson's disease. Kwon KY; Lee HM; Lee SM; Kang SH; Koh SB J Neurol Sci; 2016 Feb; 361():34-8. PubMed ID: 26810513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]